TREATING OF CANCERS OF DOCETAXEL IN COMBINATION WITH RECOMBINANT HUMANIZED MONOCLONAL ANTI-HER2 ANTIBODY

摘要

The present invention relates to a method of treating cancer, comprising administering a dose of docetaxel and a dose of rhuMAb HER2 to a patient in need thereof, wherein said dosages have a synergistic therapeutic effect when compared to the administration of docetaxel or rhuMAb HER2 alone.